Daily Market Snapshot: November 12, 2024

Daily Market Snapshot

Overview

On Tuesday, U.S. stocks edged lower as investors took profits following a post-election rally and awaited critical U.S. inflation data due later this week. The Dow Jones Industrial Average dropped 0.86%, reflecting a broad pullback as rising Treasury yields added headwinds to the equity markets. The S&P 500 and Nasdaq Composite also declined, impacted by profit-taking in growth-sensitive sectors. Stocks had seen substantial gains after Donald Trump’s election win on November 5, driven by expectations of tax cuts, deregulatory policies, and increased government spending under the new administration.

Investor enthusiasm moderated on Tuesday, with concerns rising around Trump’s policies potentially fueling inflation. The 10-year Treasury yield rose as bond investors priced in higher inflation risks, which could pressure the Federal Reserve to adjust its monetary policy sooner than anticipated. In corporate news, Tesla lost 6% after a strong rally since Election Day, while small-cap stocks represented by the Russell 2000 fell 1.8%, cooling off after reaching a three-year high.

The materials and healthcare sectors led declines in the S&P 500, with Amgen dropping over 7% following concerns about the effects of its experimental obesity drug. Meanwhile, communication services gained slightly, buoyed by steady demand in the media and telecom space. European markets also closed lower, reflecting global concerns over increased tariffs and trade restrictions expected under Trump’s administration.

  • Dow Jones Industrial Average: Fell 0.86% to 43,910.98
  • S&P 500: Lost 0.29% to 5,983.99
  • Nasdaq Composite: Declined 0.09% to 19,281.40

Fear & Greed Index

Neutral – Investor sentiment was mixed as profit-taking and inflation concerns weighed against post-election optimism for economic growth.

Sector Performance

  • Winners:
    • Communication Services: The sector rose 0.5%, with steady demand supporting media and telecom stocks amid a volatile market environment.
    • Industrials: Modest gains as defensive plays in industrials saw interest from cautious investors amid broader concerns.
  • Losers:
    • Materials: Fell 1.6%, led by declines in chemical and metals companies affected by tariff concerns.
    • Healthcare: Declined, driven by Amgen’s 7% drop following the release of data indicating potential adverse effects of its experimental drug.

Key Movers

  • Tesla (TSLA): Dropped 6% as investors took profits after a near 40% post-election surge.
  • Amgen (AMGN): Declined over 7% following concerns about its experimental obesity drug’s impact on bone density.
  • Honeywell (HON): Gained 3.8% to reach a record high after Elliott Investment took a substantial stake in the company.

Economic Data

  • Treasury Yields: The 10-year Treasury yield climbed as inflation concerns grew, presenting a potential challenge for equity markets.
  • Upcoming Inflation Data: Investors are closely monitoring Wednesday’s Consumer Price Index (CPI) and Producer Price Index (PPI) reports, which could shape Federal Reserve policy expectations.

Outlook

As U.S. inflation data is set for release, markets are poised for increased volatility. The Consumer Price Index (CPI) and Producer Price Index (PPI) data could reveal insights into inflation trends, which are of particular interest to the Federal Reserve and investors concerned about rising prices. If inflation rates exceed expectations, it may prompt the Fed to adopt a more hawkish stance, potentially raising interest rates sooner than anticipated.

Looking ahead, sectors sensitive to interest rate fluctuations, such as financials and real estate, may experience volatility. Investors are also keeping a close watch on global markets, as European Central Bank officials raised concerns about tariffs’ effects on global trade. While communication services and defensive sectors may offer short-term stability, the outlook for growth-driven sectors like tech and small caps remains uncertain amid inflation and regulatory concerns under the new administration.